GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Safe Fertility Group PCL (BKK:SAFE) » Definitions » Net Current Asset Value

Safe Fertility Group PCL (BKK:SAFE) Net Current Asset Value : ฿4.67 (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Safe Fertility Group PCL Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Safe Fertility Group PCL's net current asset value per share for the quarter that ended in Jun. 2024 was ฿4.67.

The historical rank and industry rank for Safe Fertility Group PCL's Net Current Asset Value or its related term are showing as below:

BKK:SAFE' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.25   Med: 4.18   Max: 4.57
Current: 3.3

During the past 3 years, the highest Price-to-Net-Current-Asset-Value Ratio of Safe Fertility Group PCL was 4.57. The lowest was 3.25. And the median was 4.18.

BKK:SAFE's Price-to-Net-Current-Asset-Value is ranked better than
69.92% of 256 companies
in the Healthcare Providers & Services industry
Industry Median: 6.03 vs BKK:SAFE: 3.30

Safe Fertility Group PCL Net Current Asset Value Historical Data

The historical data trend for Safe Fertility Group PCL's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Safe Fertility Group PCL Net Current Asset Value Chart

Safe Fertility Group PCL Annual Data
Trend Dec21 Dec22 Dec23
Net Current Asset Value
2.68 3.09 4.38

Safe Fertility Group PCL Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Net Current Asset Value Get a 7-Day Free Trial - 2.91 4.38 4.64 4.67

Competitive Comparison of Safe Fertility Group PCL's Net Current Asset Value

For the Medical Care Facilities subindustry, Safe Fertility Group PCL's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Safe Fertility Group PCL's Price-to-Net-Current-Asset-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Safe Fertility Group PCL's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Safe Fertility Group PCL's Price-to-Net-Current-Asset-Value falls into.



Safe Fertility Group PCL Net Current Asset Value Calculation

Safe Fertility Group PCL's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1571.326-235.707-4.128-0)/303.948
=4.38

Safe Fertility Group PCL's Net Current Asset Value (NCAV) per share for the quarter that ended in Jun. 2024 is calculated as

Net Current Asset Value Per Share(Q: Jun. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1648.844-213.743-14.918-0)/303.948
=4.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Safe Fertility Group PCL  (BKK:SAFE) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Safe Fertility Group PCL Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Safe Fertility Group PCL's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Safe Fertility Group PCL Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ploenchit Road, No. 496, 498, 500, 502 , Amarin Plaza Building, 16-18th Floor, Lumpini, Pathumwan, Bangkok, THA, 10330
Safe Fertility Group PCL operations include Obstetrics and Gynecology hospital and Medical laboratory and Cosmetic dermatology. Majority of the revenue is generated from Obstetrics and Gynecology hospital business segment and provides treatment services for infertility using medical assisted reproductive technology.